Shi YK - Search Results

1

[The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease].

Zhu WJ, Wang J, He XH, Qin Y, Yang S, Hu XS, Wang HY, Huang J, Zhou AP, Ma F, Shi YK, Zhou SY. Zhu WJ, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):305-311. doi: 10.3760/cma.j.cn112152-20200303-00166. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32133833 Chinese.

2

[Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].

Shi YK, Zhou JC, Feng FY. Shi YK, et al. Zhonghua Zhong Liu Za Zhi. 1994 May;16(3):207-10. Zhonghua Zhong Liu Za Zhi. 1994. PMID: 7525173 Clinical Trial. Chinese.

3

[Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].

Shi YK, Feng FY, Sun Y. Shi YK, et al. Zhonghua Nei Ke Za Zhi. 1994 Nov;33(11):739-42. Zhonghua Nei Ke Za Zhi. 1994. PMID: 7541325 Clinical Trial. Chinese.

4

[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].

Shi YK, Sun Y, Su M. Shi YK, et al. Zhonghua Zhong Liu Za Zhi. 1994 Sep;16(5):356-9. Zhonghua Zhong Liu Za Zhi. 1994. PMID: 7895587 Clinical Trial. Chinese.

5

Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.

Li B, Yang JL, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang S, Zhang CG. Li B, et al. Among authors: shi yk. Cytotherapy. 2009;11(3):362-71. doi: 10.1080/14653240802582067. Cytotherapy. 2009. PMID: 19037766

6

[Clinical features and prognosis of CD20-positive classical Hodgkin lymphoma].

Qin Y, Kang SY, He XH, Zhou SY, Liu P, Yang JL, Zhang CG, Yang S, Gui L, Shi YK. Qin Y, et al. Among authors: shi yk. Zhonghua Yi Xue Za Zhi. 2016 Jul 26;96(28):2224-8. doi: 10.3760/cma.j.issn.0376-2491.2016.28.005. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27480653 Chinese.

7

[Clinical features and outcomes: analysis of 9 cases of HIV-negtive plasmablastic lymphoma].

Gui L, He XH, Liu P, Yang JL, Qin Y, Zhou SY, Yang S, Zhang CG, Shi YK. Gui L, et al. Among authors: shi yk. Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):762-767. doi: 10.3760/cma.j.issn.0253-2727.2016.09.007. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27719718 Free PMC article. Chinese.

8

[Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma].

Shi YW, Liu P, Zhou SY, Yang JL, Han XH, He XH, Zhang CG, Gui L, Qin Y, Yang S, Zhao LY, Yao JR, Zhang SX, Wu SK, Pan F, Sun Y, Shi YK. Shi YW, et al. Among authors: shi yk. Zhonghua Xue Ye Xue Za Zhi. 2017 Aug 14;38(8):716-719. doi: 10.3760/cma.j.issn.0253-2727.2017.08.013. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28954353 Free PMC article. Chinese. No abstract available.

9

[The development of biosimilars in oncology].

Jiang SY, Shi YK. Jiang SY, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2017 Oct 23;39(10):721-725. doi: 10.3760/cma.j.issn.0253-3766.2017.10.001. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29061013 Chinese.

10

[Considerations for anti-cancer drug application by single arm trials].

Zhou M, Chen XY, Zhang H, Xia L, Tong X, Zou LM, Hao RM, Zhao X, Shi YK, Yang ZM. Zhou M, et al. Among authors: shi yk. Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):58-62. doi: 10.3760/cma.j.issn.0253-3766.2018.01.011. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29365420 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page